Table 1 Clinical-pathological features of the 20 liver cancer patients
From: Epigenetic silencing of glutaminase 2 in human liver and colon cancers
Characteristics | Gls2-methylated | Gls2-unmethylated |
|---|---|---|
Age, years | 51 ± 10.6 | 53 ± 12.9 |
(n) | (13) | (7) |
Gender | ||
M | 11 (84.6%) | 6 (85.7%) |
F | 2 (15.4) | 1 (14.3%) |
HBV infection | ||
Positive | 10 (76.9%) | 5 (71.4%) |
Negative | 3 (23.1%) | 2 (28.6%) |
AFP level | ||
Normal | 4 (30.8%) | 3 (42.9%) |
Abnormal | 9 (69.2%) | 4 (57.1%) |
TNM stage | ||
I-II | 3 (23.1%) | 2 (28.6%) |
III-IV | 10 (76.9%) | 5 (71.4%) |